Table 3. Clinicopathological parameters in 167 patients according to the level of the VASH1 density.
| |
No. of patients (%) |
|
|
|---|---|---|---|
| Characteristic | Patients with VASH1 density <12 per mm2 | Patients with VASH1 density ≧12 per mm2 | P-value |
| No. of patients |
83 |
84 |
|
|
Age (years) | |||
| <65 | 53 (63.9) | 46 (54.8) | 0.271 |
| ≧65 |
30 (36.1) |
38 (45.2) |
|
|
PSA | |||
| <15 | 72 (86.7) | 66 (78.6) | 0.220 |
| ≧15 |
11 (13.3) |
18 (21.4) |
|
|
Gleason score | |||
| ≦6 | 48 (57.8) | 21 (25.0) | <0.001 |
| ≧7 |
35 (42.2) |
63 (75.0) |
|
|
Pathological T stage | |||
| ≦pT2 | 65 (78.3) | 48 (57.1) | 0.005 |
| ≧pT3 |
18 (21.7) |
36 (42.9) |
|
|
MVD | |||
| <120 per mm2 | 62 (74.7) | 21 (25.0) | <0.001 |
| ≧120 per mm2 | 21 (25.3) | 63 (75.0) | |
Abbreviations: MVD=microvessel density; PSA=prostate-specific antigen; VASH1=vasohibin-1.